live healthily - fight aging - extend your life
"We are on the verge of a revolution in medicine: understanding, treating, and ultimately preventing the causes of degenerative aging. But medical revolutions only happen if we all stand up in support of funding and research. We did it for cancer. We're doing it for Alzheimer's. We can do it for aging - and create an era of longer, healthier lives!"
Home Search Take Action! Articles Daily News Newsletter Fight Aging! Blog Press Room Resources About Contact
Hot Topics: Activism - Anti-Aging - Calorie Restriction - Cryonics - Negligible Senescence - Our Community - Research Prizes - Stem Cells - Transhumanism
Start Here!
Are you new to healthy life extension? Click here to find out more about living a longer, healthier life. More >>
Take Action!
You can help to make therapies for aging and life extension medicine a reality. Click here to participate in improving your future health and longevity!
LM Newsletter
Sign up for our weekly newsletter! It contains news, opinions, and commentary for people interested in healthy life extension: making use of diet, lifestyle choices, technology, and proven medical advances to live longer, healthier lives.

Requested Daily News Article

Work on AGE Inhibitors (Tuesday October 16 2007)
For the same reason that repair is better than good maintenance, AGE-breakers should be better than AGE inhibitors when it comes to reducing the contribution of AGE buildup to aging. Few groups are effectively working on either, however, so I am always pleased to see more published research on the topic: "The reno- and cardiovascular-protective effects of angiotensin II receptor blockers (ARBs), have been ascribed, at least in part, to their ability to inhibit the formation of advanced glycation end products (AGEs), independently of their effect on blood pressure. They act through decreased oxidative stress, unlike previously reported AGE inhibitors which entrap reactive carbonyl (RCOs) precursors of AGEs. The hypotensive effects of ARBs', however, may limit their use. In the present study, we report the synthesis of a new AGE inhibitor, TM2002, and its effects in vitro and in vivo. ... In vivo, TM2002, given acutely or for 8 weeks, has no adverse effects. In four different rat models of renal injury [and cardiovascular injury] TM2002 improves renal and cardiovascular lesions without modification of blood pressure." Inhibitors may be useful for the class of AGEs that are in fact broken down in the body, just more slowly than they accumulate. Unfortunately, animal studies have proven to be misleading for AGE-breakers in the past; the types of AGEs important in other mammals turn out to be much less important in humans.
Link to original article  
Share |
 

Prior News

Later News

We help you stay up to date with the most interesting news in medicine, politics and the healthy life extension community. You can help us by contacting us when you see interesting items online. You can search past news postings through Google by using the form to the right.
Search Past News

   

Search